These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31607394)

  • 1. Re: Jack R. Andrews, Thomas Atwell, Grant Schmit, et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2019;76:244-51.
    Pecoraro A; Porpiglia F; Karakiewicz PI
    Eur Urol; 2020 Mar; 77(3):e74. PubMed ID: 31607394
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Potretzke AM; Larson JA; Bhayani SB
    Eur Urol; 2015 Feb; 67(2):e19-20. PubMed ID: 25269382
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Zargar H; Coelho RF; Kaouk JH
    Eur Urol; 2015 Feb; 67(2):e23. PubMed ID: 25266972
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Mouracade P
    Eur Urol; 2015 Oct; 68(4):e82-3. PubMed ID: 26033152
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e24-5. PubMed ID: 25257032
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Laguna MP
    J Urol; 2020 Jan; 203(1):27-28. PubMed ID: 31618159
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Cadeddu JA
    J Urol; 2020 Jan; 203(1):28. PubMed ID: 31618160
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Laguna MP
    J Urol; 2015 Aug; 194(2):331. PubMed ID: 26195356
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Hiury S. Andrade, Homayoun Zargar, Peter A. Caputo, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol 2016;69:1149-54.
    Shin TY; Abdel Raheem A; Rha KH
    Eur Urol; 2016 Oct; 70(4):e100-e101. PubMed ID: 26995331
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
    Takahashi T
    Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
    Kim WH; Yoon HK; Jeong CW
    Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.
    Sun M; Hansen J; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):e37-8. PubMed ID: 22172372
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Hendrik van Poppel, Luigi da Pozzo, Walter Albrecht, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.
    Ganesamoni R; Mavuduru R; Agarwal MM
    Eur Urol; 2011 Aug; 60(2):e9; author reply e10. PubMed ID: 21621322
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Percutaneous renal cryoablation: local control at mean 26 months of followup. T. D. Atwell, M. R. Callstrom, M. A. Farrell, G. D. Schmit, D. A. Woodrum, B. C. Leibovich, G. K. Chow, D. E. Patterson, M. L. Blute and J. W. Charboneau. J Urol 2010;184: 1291-1295.
    Ivanowicz AN; Wakeman CM; Gaston KE; Teigland CM
    J Urol; 2011 Sep; 186(3):1157. PubMed ID: 21784479
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Maxine Sun, Quoc-dien Trinh, Marco Bianchi, et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol 2012;61:725-31.
    Sandhu GS; Tanagho YS; Bhayani SB
    Eur Urol; 2012 Sep; 62(3):e58; author reply e59-60. PubMed ID: 22704368
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: An et al.: Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes (Urology 2017;100:151-157).
    Panaiyadiyan S; Kumar R
    Urology; 2017 May; 103():274. PubMed ID: 28237531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.